IHS Chemical Week

Regions :: India/Pakistan

Ipca suspends API shipments to US

8:59 AM MDT | July 25, 2014 | Deepti Ramesh

Ipca Laboratories (Mumbai), a manufacturer of formulations and active pharmaceutical ingredients (APIs), says it has decided to temporarily suspend API shipments from its manufacturing facility at Ratlam, India, to the United States in order to resolve issued identified during a recent US FDA inspection of that facility. Ipca received certain inspection observations in Form 483 from FDA. The voluntary suspension will also impact the company's formulations export business to the US market, since Ipca's formulations facilities at Piparia and Indore, India, use APIs...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa